Cargando…
TRIP13 overexpression in hepatocellular carcinoma: implications for poor prognosis and immune cell infiltration
PURPOSE: The overexpression of TRIP13 has been observed in many types of cancer and has been identified as an oncogene. However, its role in hepatocellular carcinoma (HCC) has not been extensively studied. This study aimed to investigate the expression of TRIP13 in HCC and its impact on immune cell...
Autores principales: | Xue, Jiapeng, Wu, Hongfen, Shi, Yun, Li, Zhi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10516817/ https://www.ncbi.nlm.nih.gov/pubmed/37740123 http://dx.doi.org/10.1007/s12672-023-00792-2 |
Ejemplares similares
-
Overexpression of GIHCG is Associated with a Poor Prognosis and Immune Infiltration in Hepatocellular Carcinoma
por: Xiao, Siyu, et al.
Publicado: (2020) -
Overexpression of POLA2 in hepatocellular carcinoma is involved in immune infiltration and predicts a poor prognosis
por: Liu, Long, et al.
Publicado: (2023) -
TRIP13 promotes tumor growth and is associated with poor prognosis in colorectal cancer
por: Sheng, Nengquan, et al.
Publicado: (2018) -
FANCI is Associated with Poor Prognosis and Immune Infiltration in Liver Hepatocellular Carcinoma
por: Hou, Yibo, et al.
Publicado: (2023) -
TRIP13 impairs mitotic checkpoint surveillance and is associated with poor prognosis in multiple myeloma
por: Tao, Yi, et al.
Publicado: (2017)